Upstate Cancer Center Active Clinical Trials

Cancer TypePrincipal InvestigatorKeyword OR
ClinicalTrials.Gov ID
 

You searched for Category (Breast): 12 trials found.

Click sort in the column header to sort records.
Study TitlePI
(NSABP B-51) A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy (NSABP B-51/RTOG 1304)
Read more
Anna Shapiro, MD
A011202: RANDOMIZED PHASE III TRIAL COMPARING AXILLARY LYMPH NODE DISSECTION TO AXILLARY RADIATION IN BREAST CANCER PATIENTS (cT1-3 N1) WHO HAVE POSITIVE SENTINEL LYMPH NODE DISEASE AFTER NEOADJUVANT CHEMOTHERAPY
Read more
Lisa M Lai, MD
A011401 - Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Read more
Mijung Lee, MD
A011502 - A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER 2 Negative Breast Cancer. The ABC Trial
Read more
Abirami Sivapiragasam
AFT-05: PALLAS: PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for hormone receptor positive (HR+) / human epidermal growth factor receptor 2 (HER2)-negative early breast cancer Obtain appropriate
Read more
Sam Benjamin, MD
ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III Study
Read more
Abirami Sivapiragasam
Comparison of Operative TO Monitoring and Endocrine Therapy (COMET) Trial for Low DCIS: A Phase III Prospective Randomized Trial
Read more
Lisa M Lai, MD
EA1131: A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Observation in Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant Chemotherapy
Read more
Mijung Lee, MD
NRG-BR003: A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Read more
Sam Benjamin, MD
Phase II Randomized Placebo-Controlled Trial of Cisplatin with or without ABT-888 (Veliparib) in Metastatic Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer
Read more
Mijung Lee, MD
Prospective Trial of Prone Whole-Breast Radiation Therapy versus Supine Whole-Breast Radiation Therapy with and without Respiratory Gating, a Dosimetric Comparison.
Read more
Anna Shapiro, MD
S1418 - A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes after Neoadjuvant Chemotherapy
Read more
Abirami Sivapiragasam

Search Again

Top